Table 1 Baseline sociodemographic and clinical characteristics of the study population

From: Parkinson’s disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial

 

Visit Group, n = 55

Diary Group, n = 51

Sensor Group, n = 50

Sociodemographic characteristics

Age, mean (SD), years

62.5 (9.05)

65.8 (10.9)

65.9 (8.85)

Age upon completing education, mean (SD), years

16.9 (4.51)

17.4 (5.60)

18.1 (6.63)

Gender, n (%)

 Men

37 (67.3)

29 (56.9)

27 (54.0)

 Women

18 (32.7)

22 (43.1)

23 (46.0)

Marital status, n (%)

 Unmarried

13 (23.6)

5 (9.80)

13 (26.0)

 Married

35 (63.6)

43 (84.3)

35 (70.0)

 Widower

7 (12.7)

3 (5.88)

2 (4.00)

Clinical characteristics

Years of disease, mean (SD)

8.76 (4.55)

8.20 (4.64)

10.2 (5.46)

Need for assistance, n (%)

5 (9.09%)

13 (25.5%)

5 (10.0%)

Hoehn & Yahr, mean (SD)

2.36 (0.52)

2.52 (0.40)

2.51 (0.47)

Percentage of OFF time, mean (SD)

29.3 (12.2)

26.9 (13.3)

31.7 (14.0)

FOG-Q (%), mean (SD)

10.1 (6.08)

10.8 (6.73)

10.8 (6.28)

PDQ-39 summary index, mean (SD)

30.7 (15.4)

36.1 (18.4)

30.5 (16.4)

UPDRS-II, mean (SD)

10.2 (5.28)

12.9 (6.65)

12.7 (5.70)

UPDRS-III, mean (SD)

18.0 (10.4)

22.9 (12.4)

22.2 (10.0)

UPDRS-IV, mean (SD)

1.55 (1.76)

1.22 (1.76)

1.78 (1.81)

  1. FOG-Q Freezing of Gait Questionnaire, PDQ-39 the 39-item PD Questionnaire, SD standard deviation, UPDRS Unified PD Rating Scale.